Literature DB >> 18417352

Expression of expanded polyglutamine targets profilin for degradation and alters actin dynamics.

Barrington G Burnett1, Jaime Andrews2, Srikanth Ranganathan2, Kenneth H Fischbeck2, Nicholas A Di Prospero2.   

Abstract

Huntington's disease is caused by polyglutamine expansion in the huntingtin protein. Huntingtin directly interacts with profilin, a major actin monomer sequestering protein and a key integrator of signals leading to actin polymerization. We observed a progressive loss of profilin in the cerebral cortex of Huntington's disease patients, and in cell culture and Drosophila models of polyglutamine disease. This loss of profilin is likely due to increased degradation through the ubiquitin proteasome system. Profilin loss reduces the F/G actin ratio, indicating a shift in actin polymerization. Overexpression of profilin abolishes mutant huntingtin toxicity in cells and partially ameliorates the morphological and functional eye phenotype and extends lifespan in a transgenic polyglutamine Drosophila model. These results indicate a link between huntingtin and profilin and implicate profilin in Huntington's disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18417352      PMCID: PMC2442575          DOI: 10.1016/j.nbd.2008.02.007

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  44 in total

1.  Silencing profilin-1 inhibits endothelial cell proliferation, migration and cord morphogenesis.

Authors:  Zhijie Ding; Anja Lambrechts; Mayur Parepally; Partha Roy
Journal:  J Cell Sci       Date:  2006-09-12       Impact factor: 5.285

Review 2.  Actin and actin-binding proteins. A critical evaluation of mechanisms and functions.

Authors:  T D Pollard; J A Cooper
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

3.  Control of profilin and actin expression in muscle and nonmuscle cells.

Authors:  G Babcock; P A Rubenstein
Journal:  Cell Motil Cytoskeleton       Date:  1993

4.  Dictyostelium amoebae that lack G-actin-sequestering profilins show defects in F-actin content, cytokinesis, and development.

Authors:  M Haugwitz; A A Noegel; J Karakesisoglou; M Schleicher
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582

5.  Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human.

Authors:  D P Huynh; K Figueroa; N Hoang; S M Pulst
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

6.  Neurodegenerative stimuli induce persistent ADF/cofilin-actin rods that disrupt distal neurite function.

Authors:  L S Minamide; A M Striegl; J A Boyle; P J Meberg; J R Bamburg
Journal:  Nat Cell Biol       Date:  2000-09       Impact factor: 28.824

7.  Preventing neurodegeneration in the Drosophila mutant bubblegum.

Authors:  K T Min; S Benzer
Journal:  Science       Date:  1999-06-18       Impact factor: 47.728

8.  Neuropathological classification of Huntington's disease.

Authors:  J P Vonsattel; R H Myers; T J Stevens; R J Ferrante; E D Bird; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1985-11       Impact factor: 3.685

9.  Suppression of polyglutamine toxicity by a Drosophila homolog of myeloid leukemia factor 1.

Authors:  Parsa Kazemi-Esfarjani; Seymour Benzer
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

10.  Expression of mutant huntingtin blocks exocytosis in PC12 cells by depletion of complexin II.

Authors:  J Michael Edwardson; Chih-Tien Wang; Belvin Gong; Andreas Wyttenbach; Jihong Bai; Meyer B Jackson; Edwin R Chapman; A Jennifer Morton
Journal:  J Biol Chem       Date:  2003-06-13       Impact factor: 5.157

View more
  17 in total

Review 1.  Modifiers and mechanisms of multi-system polyglutamine neurodegenerative disorders: lessons from fly models.

Authors:  Moushami Mallik; Subhash C Lakhotia
Journal:  J Genet       Date:  2010-12       Impact factor: 1.166

2.  Multiple phenotypes in Huntington disease mouse neural stem cells.

Authors:  James J Ritch; Antonio Valencia; Jonathan Alexander; Ellen Sapp; Leah Gatune; Gavin R Sangrey; Saurabh Sinha; Cally M Scherber; Scott Zeitlin; Ghazaleh Sadri-Vakili; Daniel Irimia; Marian Difiglia; Kimberly B Kegel
Journal:  Mol Cell Neurosci       Date:  2012-04-06       Impact factor: 4.314

Review 3.  Cofilin and profilin: partners in cancer aggressiveness.

Authors:  Joelle V F Coumans; Rhonda J Davey; Pierre D J Moens
Journal:  Biophys Rev       Date:  2018-07-19

Review 4.  Neurogenic and myogenic contributions to hereditary motor neuron disease.

Authors:  Katherine V Bricceno; Kenneth H Fischbeck; Barrington G Burnett
Journal:  Neurodegener Dis       Date:  2012-02-09       Impact factor: 2.977

Review 5.  Animal models of polyglutamine diseases and therapeutic approaches.

Authors:  J Lawrence Marsh; Tamas Lukacsovich; Leslie Michels Thompson
Journal:  J Biol Chem       Date:  2008-10-28       Impact factor: 5.157

6.  F-actin binding regions on the androgen receptor and huntingtin increase aggregation and alter aggregate characteristics.

Authors:  Suzanne Angeli; Jieya Shao; Marc I Diamond
Journal:  PLoS One       Date:  2010-02-04       Impact factor: 3.240

7.  Phosphorylation of profilin by ROCK1 regulates polyglutamine aggregation.

Authors:  Jieya Shao; William J Welch; Nicholas A Diprospero; Marc I Diamond
Journal:  Mol Cell Biol       Date:  2008-06-23       Impact factor: 4.272

8.  Profilin choreographs actin and microtubules in cells and cancer.

Authors:  Morgan L Pimm; Jessica Hotaling; Jessica L Henty-Ridilla
Journal:  Int Rev Cell Mol Biol       Date:  2020-07-16       Impact factor: 6.813

9.  Polyglutamine domain flexibility mediates the proximity between flanking sequences in huntingtin.

Authors:  Nicholas Stephane Caron; Carly Robyn Desmond; Jianrun Xia; Ray Truant
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-29       Impact factor: 11.205

10.  Huntingtin fibrils with different toxicity, structure, and seeding potential can be interconverted.

Authors:  J Mario Isas; Nitin K Pandey; Hui Xu; Kazuki Teranishi; Alan K Okada; Ellisa K Fultz; Anoop Rawat; Anise Applebaum; Franziska Meier; Jeannie Chen; Ralf Langen; Ansgar B Siemer
Journal:  Nat Commun       Date:  2021-07-13       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.